Mumbai: Biocon Ltd said on Tuesday it agreed to buy a 7.7 per cent stake in its research services business from a unit of GE Capital for Rs 215 crore ($35.48 million).
Biocon said it would buy the stake in Syngene, which is involved in pharmaceutical contract research and manufacturing, from GE Equity International Mauritius.
It had previously said it planned to take Syngene public, but has not given a timeline.
Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.